Founded in 2016 and based in New York, Empirican Group operates a clinical research network focused on leveraging technology to enhance the efficiency and compliance of clinical trials. The company’s core mission is to address the challenges of traditional paper-based research by utilizing electronic health records and advanced analytics to improve enrollment rates and minimize errors. Their services include providing comprehensive analytics, ensuring safety, regulatory, and protocol compliance, and embracing the latest FDA rules governing technology platforms in clinical research.

Empirican Group has made significant strides in the clinical research industry by reducing the reliance on hardcopy documentation, thereby enhancing data accuracy and operational efficiency. The company is affiliated with key figures in the medical and technological fields, although specific names are not mentioned. Their innovative approach has garnered attention from notable investors who support their mission to revolutionize clinical research. Overall, Empirican Group's impact lies in its ability to streamline clinical trials, making them safer and more efficient.